Regnum
$0
5
+$0+0% Thursday 20:00
Statistik
Harga Tertinggi Hari
0
Harga Terendah Hari
0
52M Tertinggi
0.05
52M Terendah
0
Volum
600
Volum Purata
0
Kapasiti Pasaran
2,295
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-
Pendapatan
30SepDijangka
EPS yang dijangka
N/A
EPS sebenar
-0.0043
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti RGMP. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Mengenai
Manufacturing
Consumer Services
Movies/Entertainment
Software and Other Prerecorded Compact Disc, Tape, and Record Reproducing
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.
Show more...
CEO
Pekerja
1
Negara
US
ISIN
US75915R1068